Annual ROA
-33.52%
+1.42%+4.06%
December 31, 2023
Summary
- As of February 26, 2025, FDMT annual return on assets is -33.52%, with the most recent change of +1.42% (+4.06%) on December 31, 2023.
- During the last 3 years, FDMT annual ROA has fallen by -0.80% (-2.44%).
- FDMT annual ROA is now -118.09% below its all-time high of -15.37%, reached on December 31, 2018.
Performance
FDMT ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-28.07%
-4.22%-17.69%
September 30, 2024
Summary
- As of February 26, 2025, FDMT quarterly return on assets is -28.07%, with the most recent change of -4.22% (-17.69%) on September 30, 2024.
- Over the past year, FDMT quarterly ROA has increased by +3.90% (+12.20%).
- FDMT quarterly ROA is now -49.39% below its all-time high of -18.79%, reached on September 30, 2019.
Performance
FDMT Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
FDMT ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.1% | +12.2% |
| 3 y3 years | -2.4% | +12.2% |
| 5 y5 years | -118.1% | +12.2% |
FDMT ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.9% | +4.1% | -17.7% | +27.7% |
| 5 y | 5-year | -50.9% | +47.3% | -22.1% | +73.3% |
| alltime | all time | -118.1% | +47.3% | -49.4% | +73.3% |
4D Molecular Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -28.07%(+17.7%) |
| Jun 2024 | - | -23.85%(-12.1%) |
| Mar 2024 | - | -27.12%(-16.1%) |
| Dec 2023 | -33.52%(-4.1%) | -32.32%(+1.1%) |
| Sep 2023 | - | -31.97%(-17.2%) |
| Jun 2023 | - | -38.63%(-0.5%) |
| Mar 2023 | - | -38.84%(+10.1%) |
| Dec 2022 | -34.94%(+57.2%) | -35.28%(+0.7%) |
| Sep 2022 | - | -35.02%(+1.7%) |
| Jun 2022 | - | -34.45%(+22.5%) |
| Mar 2022 | - | -28.13%(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -22.22%(-32.1%) | -25.33%(-12.6%) |
| Sep 2021 | - | -28.98%(+26.1%) |
| Jun 2021 | - | -22.98%(-16.1%) |
| Mar 2021 | - | -27.38%(-28.4%) |
| Dec 2020 | -32.72%(-48.5%) | -38.24%(-42.8%) |
| Sep 2020 | - | -66.82%(-36.3%) |
| Jun 2020 | - | -104.93%(+58.4%) |
| Mar 2020 | - | -66.24%(+40.1%) |
| Dec 2019 | -63.54%(+313.4%) | -47.27%(+151.6%) |
| Sep 2019 | - | -18.79% |
| Dec 2018 | -15.37%(-62.6%) | - |
| Dec 2017 | -41.08% | - |
FAQ
- What is 4D Molecular Therapeutics annual return on assets?
- What is the all time high annual ROA for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual ROA year-on-year change?
- What is 4D Molecular Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly ROA year-on-year change?
What is 4D Molecular Therapeutics annual return on assets?
The current annual ROA of FDMT is -33.52%
What is the all time high annual ROA for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual return on assets is -15.37%
What is 4D Molecular Therapeutics annual ROA year-on-year change?
Over the past year, FDMT annual return on assets has changed by +1.42% (+4.06%)
What is 4D Molecular Therapeutics quarterly return on assets?
The current quarterly ROA of FDMT is -28.07%
What is the all time high quarterly ROA for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly return on assets is -18.79%
What is 4D Molecular Therapeutics quarterly ROA year-on-year change?
Over the past year, FDMT quarterly return on assets has changed by +3.90% (+12.20%)